Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by ACTG

ACTG Presents Study at CROI Demonstrating Increased Risk of Obesity and Cardiometabolic Disease After Switch to Integrase Inhibitor-Containing Regimen
From ACTG
Via GlobeNewswire
ACTG Launches Second HIV Cure Clinical Trial in Africa
From ACTG
Via GlobeNewswire
ACTG Announces Publication of BEe-HIVe Trial in JAMA
From ACTG
Via GlobeNewswire
ACTG Presents Two Studies Providing Insights Into TB Treatment at Union Conference on Lung Health
From ACTG
Via GlobeNewswire
ACTG Presents Data Analysis at AIDS 2024 Showing Association between Elevated Risk of Cardiovascular Events and Abacavir Use Among People Living with HIV
From ACTG
Via GlobeNewswire
ACTG Announces Launch of its First HIV Cure Clinical Trial in Africa
From ACTG
Via GlobeNewswire
ACTG SLIM LIVER Findings Published in Annals of Internal Medicine
From ACTG
Via GlobeNewswire
ACTG Announces Launch of Clinical Trial Evaluating Combination of Three Novel Immune-based Therapies for HIV Cure
From ACTG
Via GlobeNewswire
ACTG CROI Presentation Demonstrates Superiority of HepB-CpG Vaccine Over Conventional Hepatitis B Vaccine Among People Living With HIV Who Have Not Previously Responded to Vaccination
From ACTG
Via GlobeNewswire
ACTG Presents Study at CROI Demonstrating Efficacy of Long-Acting Injectable Treatment Among People Who Had Previously Been Unable to Maintain Viral Suppression on Daily Oral Medication
From ACTG
Via GlobeNewswire
ACTG CROI Presentations Show That Semaglutide Improves Metabolic-Associated Steatotic Liver Disease Among People Living With HIV
From ACTG
Via GlobeNewswire
ACTG Presents Study at CROI Elucidating Mechanism of CMV on Aging-Related Pathways in HIV
From ACTG
Via GlobeNewswire
ACTG Announces Launch of Clinical Trial Evaluating Drug-Drug Interaction in Shortened Tuberculosis Regimen Among People Living with HIV
From ACTG
Via GlobeNewswire
ACTG Announces Launch of Clinical Trial Evaluating Novel Treatment for Tuberculous Meningitis
From ACTG
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.